MedTrace Logo

Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201

NCT00230490 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2019-11-29

No results posted yet for this study

Summary

Compare the long-term safety of pradefovir to adefovir dipivoxyl

Conditions

  • Hepatitis B, Chronic

Interventions

DRUG

pradefovir mesylate

DRUG

adefovir dipivoxyl

Sponsors & Collaborators

  • Bausch Health Americas, Inc.

    lead INDUSTRY

Principal Investigators

  • Ralph T. Doyle · Bausch Health Americas, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Completion
2007-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00230490 on ClinicalTrials.gov